This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27-29, 2020.
At the end of this CME/CE activity, participants should be able to evaluate the latest clinical evidence on the safety and efficacy of neurosteroids in treating mood disorders.
This activity is supported by CME Outfitters.
Physicians, physician assistants, nurse practitioners, nurses, and other healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Zorumski reports that he receives grant support from the Bantly Foundation; National Institute of Mental Health (NIMH); and Sage Therapeutics, Inc. He is a consultant for Sage Therapeutics, Inc.; and Takeda Pharmaceuticals U.S.A., Inc. He is a stock shareholder (directly purchased) of Sage Therapeutics, Inc. He holds patents for Neurosteroid analogs & GABA receptors; redox reagents & T-channels; and oxysterols as neuroprotectants.
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Kashemi Rorie, PhD (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
While credit is no longer available, the Annual Chair Summit Master Class for Neuroscience Professional Development has made recordings available for a fee of $5 each, or $50 for the complete set of sessions.
Call us at (877) CME-PROS or (877) 263-7767.